Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

FibroBiologics, Inc. - Common Stock (NQ:FBLG)

0.9507 -0.0593 (-5.87%)
Streaming Delayed Price Updated: 11:42 AM EDT, Jun 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Research
Quarterly Reports Insider Filings Other Filings

All News about FibroBiologics, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
News headline image
FibroBiologics to Host In-Person Analyst Day to Provide Research & Development Updates
FibroBiologics to also present at the BIO CEO & Investor Conference 
From Fibrobiologics, Inc.
Via GlobeNewswire
News headline image
Stay updated with the stocks that are on the move in today's pre-market session. ↗
Let's have a look at what is happening on the US markets before the opening bell on Thursday. Below you can find the top gainers and losers in today's pre-market session. 
Via Chartmill
News headline image
FibroBiologics Closes Second $5 Million Tranche of $25 Million Financing
From Fibrobiologics, Inc.
Via GlobeNewswire
News headline image
D. Boral Capital Served as Exclusive Placement Agent to FibroBiologics, Inc. (Nasdaq: FBLG) in connection with its $25.0 Million Financing
From D. Boral Capital
Via GlobeNewswire
News headline image
FibroBiologics Announces $25 Million Financing
From Fibrobiologics, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
FibroBiologics Files Patent Application for a Cell-based Therapeutic for the Treatment Of Splenomegaly
From Fibrobiologics, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
FibroBiologics Files Patent Application Covering Reduction of Blood Clots Associated with Instant Blood-Mediated Inflammatory Reaction (IBMIR) in Cell-Based Therapeutics
From Fibrobiologics, Inc.
Via GlobeNewswire
News headline image
FibroBiologics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
From Fibrobiologics, Inc.
Via GlobeNewswire
News headline image
This NANO Nuclear Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday ↗
 
Via Benzinga
News headline image
FibroBiologics Announces Updates for Novel Artificial Thymus Organoid Technology
From Fibrobiologics, Inc.
Via GlobeNewswire
News headline image
FibroBiologics to Present at the 2024 ThinkEquity Conference and BIO-Europe 2024
From Fibrobiologics, Inc.
Via GlobeNewswire
News headline image
FibroBiologics and Charles River Announce Collaboration to Manufacture Fibroblast Cell-based Therapies for Chronic Diseases
From Fibrobiologics, Inc.
Via GlobeNewswire
News headline image
FibroBiologics Issued Patent for Fibroblast Delivery of Tumor Inhibitory Agents by the European Patent Office
From Fibrobiologics, Inc.
Via GlobeNewswire
News headline image
FibroBiologics to Participate in a Fireside Chat at 2024 Maxim Healthcare Virtual Summit
From Fibrobiologics, Inc.
Via GlobeNewswire
News headline image
FibroBiologics to Present at 2024 Cell & Gene Meeting on the Mesa
Chief Scientific Officer, Hamid Khoja, Ph.D., to provide update on Psoriasis and Wound Care programs 
From Fibrobiologics, Inc.
Via GlobeNewswire
News headline image
FibroBiologics Engages Southern Star Research as CRO in Australia
Southern Star Research will provide CRO services for FibroBiologics in Australia 
From Fibrobiologics, Inc.
Via GlobeNewswire
News headline image
FibroBiologics Announces Filing of Patent Application for Generation of Three-dimensional Organoids using Fibroblast Cell-Based Technology
From Fibrobiologics, Inc.
Via GlobeNewswire
News headline image
FibroBiologics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
From Fibrobiologics, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
 
Via Benzinga
News headline image
FibroBiologics Announces Filing of Patent Application for Wound Healing Using an Adhesive Bandage with Fibroblast Cell-Based Technology
From Fibrobiologics, Inc.
Via GlobeNewswire
News headline image
FibroBiologics Files 2024 Second Quarter Report
From Fibrobiologics, Inc.
Via GlobeNewswire
News headline image
FibroBiologics to Present at JonesTrading Healthcare Summit 2024
From Fibrobiologics, Inc.
Via GlobeNewswire
News headline image
FibroBiologics Announces Preliminary Proof of Concept for Novel Artificial Thymus Organoid Technology
From Fibrobiologics, Inc.
Via GlobeNewswire
News headline image
FibroBiologics Set to Join Russell 2000® Index
From Fibrobiologics, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Vail Resorts Posts Downbeat Q3 Results, Joins Concrete Pumping, DocuSign And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
 
Via Benzinga
News headline image
FibroBiologics to Present at Extracellular Matrix Pharmacology Congress 2024
From Fibrobiologics, Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.